Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Semaglutide Clinical Trials Semaglutide has been tested in several large studies
Possibly adding a new entrant to the highly competitive diabetes/weight loss market, Roche has announced positive interim results from an ongoing Phase I trial for its oral small molecule GLP-1 receptor agonist, CT996
Each targets similar metabolic pathways while offering patients flexibility in administration and dosing
GLP-1: The trusted option with a proven track record for sustained weight loss, cardiovascular protection, and long-term health benefits
US$ 26.70
US$ 25.48
US$ 22.99
US$ 22.90
US$ 26.81
